| PLIP: fully automated protein–ligand interaction profiler S Salentin, S Schreiber, VJ Haupt, MF Adasme, M Schroeder Nucleic acids research 43 (W1), W443-W447, 2015 | 599 | 2015 |
| Polypharmacology rescored: Protein–ligand interaction profiles for remote binding site similarity assessment S Salentin, VJ Haupt, S Daminelli, M Schroeder Progress in biophysics and molecular biology 116 (2-3), 174-186, 2014 | 62 | 2014 |
| UniLectin3D, a database of carbohydrate binding proteins with curated information on 3D structures and interacting ligands F Bonnardel, J Mariethoz, S Salentin, X Robin, M Schroeder, S Perez, ... Nucleic acids research 47 (D1), D1236-D1244, 2019 | 28 | 2019 |
| Discovery of Mycobacterium tuberculosis InhA Inhibitors by Binding Sites Comparison and Ligands Prediction T Štular, S Lešnik, K Rožman, J Schink, M Zdouc, A Ghysels, F Liu, ... Journal of medicinal chemistry 59 (24), 11069-11078, 2016 | 19 | 2016 |
| From malaria to cancer: Computational drug repositioning of amodiaquine using PLIP interaction patterns S Salentin, MF Adasme, JC Heinrich, VJ Haupt, S Daminelli, Y Zhang, ... Scientific reports 7 (1), 1-13, 2017 | 16 | 2017 |
| Current and future roles of artificial intelligence in medicinal chemistry synthesis TJ Struble, JC Alvarez, SP Brown, M Chytil, J Cisar, RL DesJarlais, ... Journal of medicinal chemistry 63 (16), 8667-8682, 2020 | 15 | 2020 |
| Computational drug repositioning by target hopping: A use case in chagas disease V Joachim Haupt, J E Aguilar Uvalle, S Salentin, S Daminelli, F Leonhardt, ... Current pharmaceutical design 22 (21), 3124-3134, 2016 | 13 | 2016 |
| Backbone brackets and arginine tweezers delineate class I and class II aminoacyl tRNA synthetases F Kaiser, S Bittrich, S Salentin, C Leberecht, VJ Haupt, S Krautwurst, ... PLoS computational biology 14 (4), e1006101, 2018 | 10 | 2018 |
| MAGPIE: Simplifying access and execution of computational models in the life sciences C Baldow, S Salentin, M Schroeder, I Roeder, I Glauche PLoS computational biology 13 (12), e1005898, 2017 | 4 | 2017 |
| Structure-based drug repositioning explains ibrutinib as VEGFR2 inhibitor MF Adasme, D Parisi, K Van Belle, S Salentin, VJ Haupt, GS Jennings, ... Plos one 15 (5), e0233089, 2020 | 2 | 2020 |
| Computational drug repositioning for Chagas Disease using protein-ligand interaction profiling A Juárez-Saldivar, M Schroeder, S Salentin, VJ Haupt, E Saavedra, ... International journal of molecular sciences 21 (12), 4270, 2020 | 2 | 2020 |
| Characterization of Amino Acid Recognition in Aminoacyl-tRNA Synthetases F Kaiser, S Krautwurst, S Salentin, VJ Haupt, C Leberecht, S Bittrich, ... BioRxiv, 606459, 2019 | 2 | 2019 |
| The structural basis of the genetic code: amino acid recognition by aminoacyl-tRNA synthetases F Kaiser, S Krautwurst, S Salentin, VJ Haupt, C Leberecht, S Bittrich, ... Scientific reports 10 (1), 1-17, 2020 | 1 | 2020 |
| Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning MF Adasme, SN Bolz, L Adelmann, S Salentin, VJ Haupt, ... International journal of molecular sciences 21 (22), 8809, 2020 | | 2020 |
| In Silico Identification of Novel Cancer Drugs with 3D Interaction Profiling S Salentin Technische Universität Dresden, 2017 | | 2017 |
| One Step further towards Molecular Evolution: Structural Analysis of Class II Aminoacyl tRNA Synthetases S Krautwurst, C Leberecht, S Bittrich, S Salentin, F Kaiser, VJ Haupt, ... | | |
| Binding Mode Characterization of Class II Aminoacyl tRNA Synthetases F Kaiser, S Salentin, S Bittrich, C Leberecht, V Joachim, MS Haupt, ... | | |
Michael SchroederProfessor in Bioinformatics, TU DresdenBestätigte E-Mail-Adresse bei biotec.tu-dresden.de
